https://orcid.org/0000-0003-3205-3388
Citations (96)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Taqwa Al-Kofahi, Bahaa Altrad, Haneen Amawi, Alaa A Aljabali, Yousef M Abul-Haija & Mohammad A Obeid. (2024) Paclitaxel-Loaded Niosomes in Combination with Metformin: Development, Characterization and Anticancer Potentials. Therapeutic Delivery 15:2, pages 109-118.
Read now
Read now
Aiman Moldasheva, Laura Bakyt, Denis Bulanin & Mohamad Aljofan. (2023) The Impact of Cellular Environment on In Vitro Drug Screening. Future Science OA 9:9.
Read now
Read now
Zhibek Bekezhankyzy, Sholpan Nurzhan, Nurken Berdigaliyev, Shynggys Sergazy, Tilektes Maulenkul & Mohamad Aljofan. (2023) The Antiproliferative Potential and Mechanism of Action of Metformin in MCF-7 Cells. Future Science OA 9:5.
Read now
Read now
Hadeer Ehab Barakat, Raghda R. S. Hussein, Ahmed Abdullah Elberry, Mamdouh Ahmed Zaki & Mamdouh Elsherbiny Ramadan. (2022) Factors influencing the anticancer effects of metformin on breast cancer outcomes: a systematic review and meta-analysis. Expert Review of Anticancer Therapy 22:4, pages 415-436.
Read now
Read now
Ez Alddin Rajjoub Al-Mahdi, Vivencio Barrios & Jose L Zamorano. (2021) Metformin in the Era of New Antidiabetics. Future Cardiology 17:3, pages 475-485.
Read now
Read now
Nurken Berdigaliyev & Mohamad Aljofan. (2020) An Overview of Drug Discovery and Development. Future Medicinal Chemistry 12:10, pages 939-947.
Read now
Read now
Sangeetha Mathavan, Corina M Ionescu, Bozica Kovacevic, Momir Mikov, Svetlana Golocorbin-Kon, Armin Mooranian, Crispin R Dass & Hani Al-Salami. (2020) Histological Effects of Pharmacologically Active Human Bile Acid nano/micro-particles in Type-1 Diabetes. Therapeutic Delivery 11:3, pages 157-171.
Read now
Read now
Articles from other publishers (89)
Rüdiger Landgraf, Jens Aberle, Andreas L. Birkenfeld, Baptist Gallwitz, Monika Kellerer, Harald H. Klein, Dirk Müller-Wieland, Michael A. Nauck, Tobias Wiesner & Erhard Siegel. (2024) Therapie des Typ-2-DiabetesTreatment of type 2 diabetes. Die Diabetologie 20:2, pages 212-260.
Crossref
Crossref
Lucy Huang, Charmaine M. Woods, Nuwan Dharmawardana, Michael Z. Michael & Eng Hooi Ooi. (2024) The mechanisms of action of metformin on head and neck cancer in the pre-clinical setting: a scoping review. Frontiers in Oncology 14.
Crossref
Crossref
Amina Kotha, Shihab Ahmad, Irin Dewan, Mohiuddin Bhuiyan, Fahad Imtiaz Rahman, Isa Naina Mohamed & Md Reza. (2023) Metformin Hydrochloride Loaded Mucoadhesive Microspheres and Nanoparticles for Anti-Hyperglycemic and Anticancer Effects Using Factorial Experimental Design. Drug Design, Development and Therapy Volume 17, pages 3661-3684.
Crossref
Crossref
Yuval Bin Kanner, Qiu-Xu Teng, Assaf Ganoth, Dan Peer, Jing-Quan Wang, Zhe-Sheng Chen & Yossi Tsfadia. (2023) Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR. Frontiers in Pharmacology 14.
Crossref
Crossref
B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, Saad Ali Alshehri, Shadma Wahab, Lalitkumar K. Vora, Raghu Raj Singh Thakur & Prashant Kesharwani. (2023) The cubosome-based nanoplatforms in cancer therapy: Seeking new paradigms for cancer theranostics. Environmental Research 237, pages 116894.
Crossref
Crossref
Jiayi Liu, Jing Zhao & Xue Qiao. (2023) Research Progress of Metformin in the Treatment of Oral Squamous Cell Carcinoma. Endocrinology 164:11.
Crossref
Crossref
Youssof Sefidi-Heris, Ehsan Zarei & Iraj Saadat. (2023) Metformin and p-coumaric acid downregulate the expression of hTERT in gastric cancer cell line AGS. Gene Reports 32, pages 101795.
Crossref
Crossref
Jisha Pillai U, Anindita Ray, Meenu Maan & Mainak Dutta. (2023) Repurposing drugs targeting metabolic diseases for cancer therapeutics. Drug Discovery Today 28:9, pages 103684.
Crossref
Crossref
Sholpan Nurzhan, Zhibek Bekezhankyzy, Hong Ding, Nurken Berdigaliyev, Shynggys Sergazy, Alexander Gulyayev, Zarina Shulgau, Christopher R. Triggle & Mohamad Aljofan. (2023) The Effect of Different Glucose Concentrations on the Antiproliferative Activity of Metformin in MCF-7 Breast Cancer Cells. Pharmaceutics 15:9, pages 2186.
Crossref
Crossref
Manoj B. Sharma, Özlem Kap, Hend A. M. Abdelmohsen, Mark D. Ashton, Garry R. Harper, Melike Firlak, Jasmine E. Aaltonen, Kerry A. Bolland, Ryan Bragg, Sarah Deeley, Ella Francis, Nahin Kazi, Bethany L. Mapley, Vasileios Oikonomou, Amal D. Aljohani, David Cheneler, Volkan Kilic, Nesrin Horzum & John G. Hardy. (2023) Poly(2‐Hydroxyethyl Methacrylate) Hydrogel‐Based Microneedles for Metformin Release. Global Challenges 7:8.
Crossref
Crossref
Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary, Sebastiano Buti, Melissa Bersanelli, Paola Bordi, Giuseppe Tonini, Bruno Vincenzi, Marco Tucci, Alessandro Russo, Francesco Pantano, Marco Russano, Luigia Stefania Stucci, Maria Chiara Sergi, Martina Falconi, Maria Antonietta Zarzana, Daniele Santini, Francesco Spagnolo, Enrica T. Tanda, Francesca Rastelli, Francesca Chiara Giorgi, Federica Pergolesi, Raffaele Giusti, Marco Filetti, Francesca Lo Bianco, Paolo Marchetti, Andrea Botticelli, Alain Gelibter, Marco Siringo, Marco Ferrari, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Michele Ghidini, Olga Nigro, Francesco Grossi, Michele De Tursi, Pietro Di Marino, Paola Queirolo, Sergio Bracarda, Serena Macrini, Alessandro Inno, Federica Zoratto, Enzo Veltri, Chiara Spoto, Maria Grazia Vitale, Katia Cannita, Alessandra Gennari, Daniel L. Morganstein, Domenico Mallardo, Lorenzo Nibid, Giovanna Sabarese, Leonardo Brunetti, Giuseppe Perrone, Paolo A. Ascierto, Corrado Ficorella & David J. Pinato. (2023) Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer. Clinical Cancer Research 29:14, pages 2714-2724.
Crossref
Crossref
Rüdiger Landgraf, Jens Aberle, Andreas L. Birkenfeld, Baptist Gallwitz, Monika Kellerer, Harald H. Klein, Dirk Müller-Wieland, Michael A. Nauck, Tobias Wiesner & Erhard Siegel. (2023) Therapie des Typ-2-DiabetesTreatment of type 2 diabetes. Die Diabetologie 19:5, pages 658-697.
Crossref
Crossref
Mohamad Ali Hijazi, André Gessner & Nahed El-Najjar. (2023) Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp. Cancers 15:12, pages 3199.
Crossref
Crossref
Bustanur Rosidi, Diana Priyatno, Teguh Pribadi Putra & Irawan Yusuf. (2023) Metformin Induces a Caspase 3-Unrelated Apoptosis in Human Colorectal Cancer Cell Lines HCT116 and SW620. Cancer Management and Research Volume 15, pages 475-485.
Crossref
Crossref
Carsten Lange, Jana Brüggemann, Theresa Thüner, Julia Jauckus, Thomas Strowitzki & Ariane Germeyer. (2023) Changes in the expression of cancer- and metastasis-related genes and proteins after metformin treatment under different metabolic conditions in endometrial cancer cells. Heliyon 9:6, pages e16678.
Crossref
Crossref
Yanting Lin, Yiming Liu, Zhenhua Gao, Dongquan Jing, Ran Bi, Xinmeng Cui, Qiuhua Cao, Qixiang Zhao, Rui Gao, Yali Su, Siliang Liu, Mingrui Zhao, Yong Yang, Anqi Chen, Beiying Dai & Xinghua Gao. (2023) Beta-adrenergic receptor blocker propranolol triggers anti-tumor immunity and enhances irinotecan therapy in mice colorectal cancer. European Journal of Pharmacology 949, pages 175718.
Crossref
Crossref
Turab Mohammed, Michael Bowe, Alexandria Plant, Mario Perez, Carlos A Alvarez & Eric M Mortensen. (2023) Metformin Use Is Associated With Lower Mortality in Veterans With Diabetes Hospitalized With Pneumonia. Clinical Infectious Diseases 76:7, pages 1237-1244.
Crossref
Crossref
Yen Hsu, Chung Y. Hsu & Yung-Shuo Kao. (2023) The Association between Metformin and the Cancer-Specific Mortality Rate in Nasopharyngeal Cancer Patients: Real-World Evidence. Current Oncology 30:4, pages 3940-3950.
Crossref
Crossref
Amirreza Naseri, Sarvin Sanaie, Sina Hamzehzadeh, Sepideh Seyedi-Sahebari, Mohammad-Salar Hosseini, Elnaz Gholipour-khalili, Ehsan Rezazadeh-Gavgani, Reza Majidazar, Parya Seraji, Sara Daneshvar & Erfan Rezazadeh-Gavgani. (2023) Metformin: new applications for an old drug. Journal of Basic and Clinical Physiology and Pharmacology 34:2, pages 151-160.
Crossref
Crossref
Bryan Alejandro Espinosa-Rodriguez, Daniela Treviño-Almaguer, Pilar Carranza-Rosales, Monica Azucena Ramirez-Cabrera, Karla Ramirez-Estrada, Eder Ubaldo Arredondo-Espinoza, Luis Fernando Mendez-Lopez & Isaias Balderas-Renteria. (2023) Metformin May Alter the Metabolic Reprogramming in Cancer Cells by Disrupting the L-Arginine Metabolism: A Preliminary Computational Study. International Journal of Molecular Sciences 24:6, pages 5316.
Crossref
Crossref
Miran Rada, Lucyna Krzywon, Stephanie Petrillo, Anthoula Lazaris & Peter Metrakos. (2023) A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases. Biomedicines 11:3, pages 731.
Crossref
Crossref
Claudia Maria Jurca, Kinga Kozma, Codruta Diana Petchesi, Dana Carmen Zaha, Ioan Magyar, Mihai Munteanu, Lucian Faur, Aurora Jurca, Dan Bembea, Emilia Severin & Alexandru Daniel Jurca. (2023) Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review. Genes 14:2, pages 433.
Crossref
Crossref
Mhdia Osman, Taif Muqbel, Ahad Abduallh, Shuruq Alanazi, Nasrin E. Khalifa, Weam M. A. Khojali, Halima Mustafa Elagib, Weiam Hussein & Marwa H. Abdallah. (2023) Metformin Therapy and Breast Cancer Incidence in the Ha’il Region. Healthcare 11:3, pages 321.
Crossref
Crossref
Fan Zhang, Wei Liu, Yonggui Long & Huali Peng. (2023) Targeted Delivery of Metformin Against Lung Cancer Cells Via Hyaluronan-Modified Mesoporous Silica Nanoparticles. Applied Biochemistry and Biotechnology.
Crossref
Crossref
Maryam Keshavarz, Kan Xie, Kristina Schaaf, Daniele Bano & Dan Ehninger. (2022) Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction?. Molecular Psychiatry 28:1, pages 242-255.
Crossref
Crossref
Yan Hiu Athena Lee, Jeremy Man Ho Hui, Jeffrey Shi Kai Chan, Kang Liu, Edward C. Dee, Kenrick Ng, Pias Tang, Gary Tse & Chi Fai Ng. (2022) Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: A population‐based study. The Prostate 83:1, pages 119-127.
Crossref
Crossref
Iskra Tanushevska, Aleksandra Grozdanova, Aleksandra Kapedanovska Nestorovska, Zorica Naumovska, Aleksandar Dimkovski, Evgenija Mihajloska & Zoran Sterjev. (2022) New pharmacotherapeutic aspects associated with the use of Metformin. Macedonian Pharmaceutical Bulletin 68:03, pages 493-494.
Crossref
Crossref
Yunzhu Feng, Benzhong Jia & Zhiyong Shen. (2022) Metformin and bladder cancer: Drug repurposing as a potential tool for novel therapy: A review. Medicine 101:45, pages e31635.
Crossref
Crossref
Andreas Paraskevas, Elena Bellou, Elli Keramida, Irma Bracka, Christina Gkriniouk, Spyros Mazarakis, Ioannis Karampinis, Panagiotis Demertzis & Georgia Hardavella. (2022) Diabetes and Lung Cancer: A Sweet and Sour Relationship. Current Respiratory Medicine Reviews 18:4, pages 241-246.
Crossref
Crossref
Sanjay Goel, Ravinder Singh, Varinder Singh, Harmanjit Singh, Pratima Kumari, Hitesh Chopra, Rohit Sharma, Eugenie Nepovimova, Martin Valis, Kamil Kuca & Talha Bin Emran. (2022) Metformin: Activation of 5′ AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action. Frontiers in Genetics 13.
Crossref
Crossref
Bodo C. Melnik & Gerd Schmitz. (2022) Milk Exosomal microRNAs: Postnatal Promoters of β Cell Proliferation but Potential Inducers of β Cell De-Differentiation in Adult Life. International Journal of Molecular Sciences 23:19, pages 11503.
Crossref
Crossref
Xuewei Yin, Chunyi Lyu, Zonghong Li, Qian Wang, Yi Ding, Yan Wang, Yan Qiu, Siyuan Cui, Dadong Guo & Ruirong Xu. (2022) High Expression of ACOT2 Predicts Worse Overall Survival and Abnormal Lipid Metabolism: A Potential Target for Acute Myeloid Leukemia. Journal of Healthcare Engineering 2022, pages 1-15.
Crossref
Crossref
Rüdiger Landgraf, Jens Aberle, Andreas L. Birkenfeld, Baptist Gallwitz, Monika Kellerer, Harald Klein, Dirk Müller-Wieland, Michael A. Nauck, Tobias Wiesner & Erhard Siegel. (2022) Therapy of Type 2 Diabetes. Experimental and Clinical Endocrinology & Diabetes 130:S 01, pages S80-S112.
Crossref
Crossref
Alaa Ibrahim, Islam A. Khalil & Ibrahim M. El-Sherbiny. (2022) Development and Evaluation of Core-Shell Nanocarrier System for Enhancing the Cytotoxicity of Doxorubicin/Metformin Combination Against Breast Cancer Cell Line. Journal of Pharmaceutical Sciences 111:9, pages 2581-2591.
Crossref
Crossref
Josef Jampilek. (2022) Drug repurposing to overcome microbial resistance. Drug Discovery Today 27:7, pages 2028-2041.
Crossref
Crossref
Rüdiger Landgraf, Jens Aberle, Andreas L. Birkenfeld, Baptist Gallwitz, Monika Kellerer, Harald H. Klein, Dirk Müller-Wieland, Michael A. Nauck, Tobias Wiesner & Erhard Siegel. (2022) Therapie des Typ-2-DiabetesTreatment of type 2 diabetes. Die Diabetologie 18:5, pages 623-656.
Crossref
Crossref
Eun-Jung Rhee. (2022) Extra-Glycemic Effects of Anti-Diabetic Medications: Two Birds with One Stone?. Endocrinology and Metabolism 37:3, pages 415-429.
Crossref
Crossref
Khim Boon Tee, Luqman Ibrahim, Najihah Mohd Hashim, Mohd Zuwairi Saiman, Zaril Harza Zakaria & Hasniza Zaman Huri. (2022) Pharmacokinetic–Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes. Pharmaceutics 14:6, pages 1268.
Crossref
Crossref
Mousa Sha’at, Adrian Florin Spac, Iulian Stoleriu, Alexandra Bujor, Monica Stamate Cretan, Mihaela Hartan & Lacramioara Ochiuz. (2022) Implementation of QbD Approach to the Analytical Method Development and Validation for the Estimation of Metformin Hydrochloride in Tablet Dosage Forms by HPLC. Pharmaceutics 14:6, pages 1187.
Crossref
Crossref
Gabriel Veniamin Cozma, Alexandru Apostu, Ioana Macasoi, Cristina Adriana Dehelean, Octavian Marius Cretu, Stefania Dinu, Dan Gaiță & Aniko Manea. (2022) In Vitro and In Ovo Evaluation of the Potential Hepatoprotective Effect of Metformin. Medicina 58:6, pages 705.
Crossref
Crossref
Aiman Moldasheva, Vladimir Surov & Mohamad Aljofan. (2022) Editorial: New lights Through Old Windows: Metformin and Derivatives as Anti-Cancer Treatments. Frontiers in Pharmacology 13.
Crossref
Crossref
Daniil A. Rusanov, Jiaying Zou & Maria V. Babak. (2022) Biological Properties of Transition Metal Complexes with Metformin and Its Analogues. Pharmaceuticals 15:4, pages 453.
Crossref
Crossref
Manh Tuong Nguyen, Han-Cheol Choe, Byung-Hoon Kim & Sang-Gun Ahn. (2022) A new link between apoptosis induced by the metformin derivative HL156A and autophagy in oral squamous cell carcinoma. European Journal of Pharmacology 920, pages 174859.
Crossref
Crossref
Pınar KÖROĞLU. (2022) Prostat kanseri modelinde metformin ve matriks metalloproteinaz ilişkisine doğrudan bir köprü: oksidatif stress. Cukurova Medical Journal 47:1, pages 360-365.
Crossref
Crossref
Tsvetalina Tankova, Elżbieta Senkus, Maria Beloyartseva, Simona Borštnar, Doina Catrinoiu, Mona Frolova, Alinta Hegmane, Andrej Janež, Mladen Krnić, Zoltan Lengyel, Yiola Marcou, Laura Mazilu, Bela Mrinakova, Ruth Percik, Katarina Petrakova, Gábor Rubovszky, Margarita Tokar & Eduard Vrdoljak. (2022) Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer. Cancers 14:7, pages 1598.
Crossref
Crossref
Kayoko Morio, Yasuko Kurata, Nobuko Kawaguchi-Sakita, Akihiro Shiroshita & Yuki Kataoka. (2021) Efficacy of Metformin in Patients With Breast Cancer Receiving Chemotherapy or Endocrine Therapy: Systematic Review and Meta-analysis. Annals of Pharmacotherapy 56:3, pages 245-255.
Crossref
Crossref
Masahiro Takahara, Akinobu Takaki, Sakiko Hiraoka, Kensuke Takei, Eriko Yasutomi, Shoko Igawa, Shumpei Yamamoto, Shohei Oka, Masayasu Ohmori, Yasushi Yamasaki, Toshihiro Inokuchi, Hideaki Kinugasa, Keita Harada, Heiichiro Udono & Hiroyuki Okada. (2022)
Metformin ameliorates chronic colitis in a mouse model by regulating interferon‐γ‐producing lamina propria CD4
+
T cells through AMPK activation
. The FASEB Journal 36:2.
Crossref
Crossref
Othman Makki Sagheer, Mohammed Hassan Mohammed, Jaafar S. Wadi & Zaid O. Ibraheem. (2022) Studying the Cytotoxic Activity of Newly Designed and Synthesized HDAC Inhibitors Derivatives of Pentanoyl Anilide‐5‐Biguanide. Macromolecular Symposia 401:1.
Crossref
Crossref
Manrose Singh, Akito T. Nicol, Jaclyn DelPozzo, Jia Wei, Mandeep Singh, Tony Nguyen, Satoru Kobayashi & Qiangrong Liang. (2022) Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Gulzhanat Aimagambetova, Sanja Terzic, Antonio Simone Laganà, Gauri Bapayeva, Philip la Fleur & Milan Terzic. (2021) Contemporary Fertility-Sparing Management Options of Early Stage Endometrioid Endometrial Cancer in Young Nulliparous Patients. Journal of Clinical Medicine 11:1, pages 196.
Crossref
Crossref
Funmilayo O. Adeshakin, Adeleye O. Adeshakin, Zhao Liu, Jian Cheng, Pengchao Zhang, Dehong Yan, Guizhong Zhang & Xiaochun Wan. (2021) Targeting Oxidative Phosphorylation-Proteasome Activity in Extracellular Detached Cells Promotes Anoikis and Inhibits Metastasis. Life 12:1, pages 42.
Crossref
Crossref
Shivshankar Thanigaimani, Tejas P. Singh, Jon Unosson, James Phie, Joseph Moxon, Anders Wanhainen & Jonathan Golledge. (2021) Editor's Choice – Association Between Metformin Prescription and Abdominal Aortic Aneurysm Growth and Clinical Events: a Systematic Review and Meta-Analysis. European Journal of Vascular and Endovascular Surgery 62:5, pages 747-756.
Crossref
Crossref
Kosta J. Popović, Dušica J. Popović, Dejan Miljković, Jovan K. Popović, Dušan Lalošević, Mihalj Poša & Ivan Čapo. (2021) Disulfiram and metformin combination anticancer effect reversible partly by antioxidant nitroglycerin and completely by NF-κB activator mebendazole in hamster fibrosarcoma. Biomedicine & Pharmacotherapy 143, pages 112168.
Crossref
Crossref
Hyun Woo Kim. (2021) Metabolomic Approaches to Investigate the Effect of Metformin: An Overview. International Journal of Molecular Sciences 22:19, pages 10275.
Crossref
Crossref
Ahmed Olatunde, Manisha Nigam, Rahul Kunwar Singh, Abhaya Shikhar Panwar, Abdulwahab Lasisi, Fahad A. Alhumaydhi, Vijay Jyoti kumar, Abhay Prakash Mishra & Javad Sharifi-Rad. (2021) Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs. Cancer Cell International 21:1.
Crossref
Crossref
Jingjing Liu, Ibrahim Knani, Miriam Gross-Cohen, Jiaxi Hu, Sumin Wang, Li Tang, Neta Ilan, Shiming Yang & Israel Vlodavsky. (2021) Role of heparanase 2 (Hpa2) in gastric cancer. Neoplasia 23:9, pages 966-978.
Crossref
Crossref
Bharat Pateliya, Vinod Burade & Sunita Goswami. (2021) Enhanced antitumor activity of doxorubicin by naringenin and metformin in breast carcinoma: an experimental study. Naunyn-Schmiedeberg's Archives of Pharmacology 394:9, pages 1949-1961.
Crossref
Crossref
Vivek P. Chavda, Yavuz Nuri Ertas, Vinayak Walhekar, Dharti Modh, Avani Doshi, Nirav Shah, Krishna Anand & Mahesh Chhabria. (2021) Advanced Computational Methodologies Used in the Discovery of New Natural Anticancer Compounds. Frontiers in Pharmacology 12.
Crossref
Crossref
Mahmoud E. Youssef, Eslam E. Abd El-Fattah, Amir M. Abdelhamid, Hanan Eissa, Eman El-Ahwany, Noha A. Amin, Helal F. Hetta, Mohamed H. Mahmoud, Gaber El-Saber Batiha, Naglaa Gobba, Ahmed Gaafar Ahmed Gaafar & Sameh Saber. (2021) Interference With the AMPKα/mTOR/NLRP3 Signaling and the IL-23/IL-17 Axis Effectively Protects Against the Dextran Sulfate Sodium Intoxication in Rats: A New Paradigm in Empagliflozin and Metformin Reprofiling for the Management of Ulcerative Colitis. Frontiers in Pharmacology 12.
Crossref
Crossref
Hsiu-Chung Cheng, Tsung-Kun Chang, Wei-Chih Su, Hsiang-Lin Tsai & Jaw-Yuan Wang. (2021) Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes. Translational Oncology 14:7, pages 101089.
Crossref
Crossref
Xiang-Nan Jiang, Yan Zhang, Wei-Ge Wang, Dong Sheng, Xiao-Yan Zhou & Xiao-Qiu Li. (2021) Alteration of Cholesterol Metabolism by Metformin Is Associated With Improved Outcome in Type II Diabetic Patients With Diffuse Large B-Cell Lymphoma. Frontiers in Oncology 11.
Crossref
Crossref
Rüdiger Landgraf, Jens Aberle, Andreas L. Birkenfeld, Baptist Gallwitz, Monika Kellerer, Harald H. Klein, Dirk Müller-Wieland, Michael A. Nauck, Hans-Martin Reuter & Erhard Siegel. (2021) Therapie des Typ-2-DiabetesTherapy of type 2 diabetes. Der Diabetologe 17:4, pages 422-447.
Crossref
Crossref
Seckin Engin, Elif Nur Barut, Aysun Celik Soysal, Oguzhan Keskin, Gokcen Kerimoglu, Mine Kadioglu & Sena Sezen. (2021) Double benefit of metformin treatment: improved bladder function in cyclophosphamide-induced cystitis and enhanced cytotoxicity in cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology 394:6, pages 1167-1175.
Crossref
Crossref
Ibrahim Y. Abdelgawad, Karim T. Sadak, Diana W. Lone, Mohamed S. Dabour, Laura J. Niedernhofer & Beshay N. Zordoky. (2021) Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence. Pharmacology & Therapeutics 221, pages 107751.
Crossref
Crossref
Yanjun Song, Pei Ma, Yu Gao, Peigen Xiao, Lijia Xu & Haibo Liu. (2021) A Bibliometrics Analysis of Metformin Development From 1980 to 2019. Frontiers in Pharmacology 12.
Crossref
Crossref
Carsten Lange, Amanda Machado Weber, Ronny Schmidt, Christoph Schroeder, Thomas Strowitzki & Ariane Germeyer. (2021) Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line. PLOS ONE 16:3, pages e0248103.
Crossref
Crossref
Namdev Dhas, Ritu Kudarha, Atul Garkal, Vivek Ghate, Shilpa Sharma, Prabhakar Panzade, Shubham Khot, Pinal Chaudhari, Ashutosh Singh, Mitali Paryani, Shaila Lewis, Neha Garg, Narinder Singh, Priyanka Bangar & Tejal Mehta. (2021) Molybdenum-based hetero-nanocomposites for cancer therapy, diagnosis and biosensing application: Current advancement and future breakthroughs. Journal of Controlled Release 330, pages 257-283.
Crossref
Crossref
Tomás Duraj, Noemí García-Romero, Josefa Carrión-Navarro, Rodrigo Madurga, Ana Ortiz de Mendivil, Ricardo Prat-Acin, Lina Garcia-Cañamaque & Angel Ayuso-Sacido. (2021) Beyond the Warburg Effect: Oxidative and Glycolytic Phenotypes Coexist within the Metabolic Heterogeneity of Glioblastoma. Cells 10:2, pages 202.
Crossref
Crossref
Othman Makki Sagheer, Mohammed Hassan Mohammed, Zaid O. Ibraheem, Jaafar S. Wadi & Mustafa F. Tawfeeq. (2021) Synthesis of gamma biguanides butyric acid analogues as HDAC inhibitors and studying their cytotoxic activity. Materials Today: Proceedings 47, pages 5983-5991.
Crossref
Crossref
Bharat Pateliya, Vinod Burade & Sunita Goswami. (2021) Combining naringenin and metformin with doxorubicin enhances anticancer activity against triple-negative breast cancer in vitro and in vivo. European Journal of Pharmacology 891, pages 173725.
Crossref
Crossref
Patricia Marie M. Lusica, Kyle Patrick Y. Eugenio, Danielle Benedict L. Sacdalan & Cecilia A. Jimeno. (2021) A systematic review and meta-analysis on the efficacy and safety of metformin as adjunctive therapy among women with metastatic breast cancer. Cancer Treatment and Research Communications 29, pages 100457.
Crossref
Crossref
Christian Bailly & Gérard Vergoten. (2020) Mechanistic insights into dimethyl cardamonin-mediated pharmacological effects: A double control of the AMPK-HMGB1 signaling axis. Life Sciences 263, pages 118601.
Crossref
Crossref
Kalpana Tilekar, Neha Upadhyay, Cristina V. Iancu, Vadim Pokrovsky, Jun-yong Choe & C.S. Ramaa. (2020) Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1874:2, pages 188457.
Crossref
Crossref
Ehtasham Ahmad, Jack Sargeant, Francesco Zaccardi, Kamlesh Khunti, David Webb & Melanie Davies. (2020) Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?. Pharmaceuticals 13:12, pages 427.
Crossref
Crossref
Verena A. Katzke, Rudolf Kaaks, Jutta Kneisel & Tilman Kühn. (2020) Diabetes und KrebsDiabetes and cancer. Der Diabetologe 16:7, pages 675-684.
Crossref
Crossref
KyeongJin Kim, Wen-Hao Yang, Youn-Sang Jung & Jong-ho Cha. (2020) A new aspect of an old friend: the beneficial effect of metformin on anti-tumor immunity. BMB Reports 53:10, pages 512-520.
Crossref
Crossref
Jae Hyung Park, Woo Yang Pyun & Hyun Woo Park. (2020) Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets. Cells 9:10, pages 2308.
Crossref
Crossref
Rüdiger Landgraf, Jens Aberle, Andreas L. Birkenfeld, Baptist Gallwitz, Monika Kellerer, Harald H. Klein, Dirk Müller-Wieland, Michael A. Nauck, Hans-Martin Reuter & Erhard Siegel. (2020) Therapie des Typ-2-Diabetes. Diabetologie und Stoffwechsel 15:S 01, pages S65-S92.
Crossref
Crossref
Samson Mathews Samuel, Elizabeth Varghese, Lenka Koklesová, Alena Líšková, Peter Kubatka & Dietrich Büsselberg. (2020) Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells. Cancers 12:9, pages 2482.
Crossref
Crossref
T. Koufakis, O. G. Mustafa, P. Zebekakis & K. Kotsa. (2020) Oral antidiabetes agents for the management of inpatient hyperglycaemia: so far, yet so close. Diabetic Medicine 37:9, pages 1418-1426.
Crossref
Crossref
George G. Chen, Peter Y.M. Woo, Stephanie C.P. Ng, George K.C. Wong, Danny T.M. Chan, Charles A. van Hasselt, Michael C.F. Tong & Wai Sang Poon. (2020) Impact of metformin on immunological markers: Implication in its anti-tumor mechanism. Pharmacology & Therapeutics 213, pages 107585.
Crossref
Crossref
Ji Hoon Jang, Eon-Gi Sung, In-Hwan Song, Tae-Jin Lee & Joo-Young Kim. (2020) Metformin induces caspase-dependent and caspase-independent apoptosis in human bladder cancer T24 cells. Anti-Cancer Drugs 31:7, pages 655-662.
Crossref
Crossref
Serpil Özsoy, Eda Becer, Hilal Kabadayı, Hafize S. Vatansever & Sevinç Yücecan. (2020) Quercetin-Mediated Apoptosis and Cellular Senescence in Human Colon Cancer. Anti-Cancer Agents in Medicinal Chemistry 20:11, pages 1387-1396.
Crossref
Crossref
Yong Chen, Fujuan Qiu, Beijia Yu, Yanjuan Chen, Fangfang Zuo, XiaoYu Zhu, Kutty Selva Nandakumar & Changhong Xiao. (2020) Metformin, an AMPK Activator, Inhibits Activation of FLSs but Promotes HAPLN1 Secretion. Molecular Therapy - Methods & Clinical Development 17, pages 1202-1214.
Crossref
Crossref
Stergios Boussios, Christos Mikropoulos, Eleftherios Samartzis, Peeter Karihtala, Michele Moschetta, Matin Sheriff, Afroditi Karathanasi, Agne Sadauskaite, Elie Rassy & Nicholas Pavlidis. (2020) Wise Management of Ovarian Cancer: On the Cutting Edge. Journal of Personalized Medicine 10:2, pages 41.
Crossref
Crossref
Chidiebere V. Ugwueze, Odunze J. Ogamba, Ekenechukwu E. Young, Belonwu M. Onyenekwe & Basil C. Ezeokpo. (2020) Metformin: A Possible Option in Cancer Chemotherapy. Analytical Cellular Pathology 2020, pages 1-10.
Crossref
Crossref
Seamas C Donnelly. (2020) Digital Health Solutions - the future - but not quite yet. QJM: An International Journal of Medicine 113:3, pages 153-154.
Crossref
Crossref
Suhaib Ibrahim Alkhamaiseh & Mohamad Aljofan. (2020) Prevalence of use and reported side effects of herbal medicine among adults in Saudi Arabia. Complementary Therapies in Medicine 48, pages 102255.
Crossref
Crossref
Samson Samuel, Elizabeth Varghese, Peter Kubatka, Chris Triggle & Dietrich Büsselberg. (2019) Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer. Biomolecules 9:12, pages 846.
Crossref
Crossref